Avanos medical, inc. (AVNS)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12
Net Sales

697,600

652,300

611,600

566,200

509,000

1,672,100

1,677,500

1,684,000

Cost of products sold

295,400

261,400

274,700

269,000

251,200

1,123,500

1,065,300

1,081,500

Gross Profit

402,200

390,900

336,900

297,200

257,800

548,600

612,200

602,500

Research and development

37,700

41,800

38,200

38,400

27,600

33,600

37,900

33,000

Selling and general expenses

399,100

340,400

321,700

346,200

349,700

424,500

351,400

343,000

Goodwill impairment

-

-

-

-

-

0

0

-

Other expense, net

-21,100

-8,200

-20,100

-19,700

-16,200

3,800

2,400

1,500

Operating Income (Loss)

-55,700

500

-43,100

-107,100

-135,700

94,300

225,300

228,000

Interest income

6,700

7,800

2,500

600

300

2,900

2,600

2,600

Interest expense

15,000

26,400

31,600

32,700

33,100

6,000

100

800

Loss Before Income Taxes

-64,000

-18,100

-72,200

-139,200

-168,500

91,200

227,800

229,800

Income tax benefit

-18,100

-9,600

-40,100

-55,900

-67,300

64,100

73,200

77,200

Loss from Continuing Operations

-45,900

-8,500

-32,100

-83,300

-101,200

-

-

-

Income from discontinued operations, net of tax

0

66,000

111,400

123,100

-325,100

-

-

-

Net Income (Loss)

-45,900

57,500

79,300

39,800

-426,300

27,100

154,600

152,600

Earnings (Loss) Per Share
Basic:
Continuing operations (in dollars per share)

-0.96

-0.18

-0.69

-1.79

-2.17

-

-

-

Discontinued operations (in dollars per share)

0.00

1.40

2.38

2.64

-6.98

-

-

-

Basic (in dollars per share)

-0.96

1.22

1.69

0.85

-9.15

0.58

3.32

3.28

Diluted:
Continuing operations (in dollars per share)

-0.96

-0.18

-0.69

-1.79

-2.17

-

-

-

Discontinued operations (in dollars per share)

0.00

1.40

2.38

2.64

-6.98

-

-

-

Diluted (in earnings per share)

-0.96

1.22

1.69

0.85

-9.15

0.58

3.32

3.28